Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suzi Afu Tablets for stable vitiligo
CTR20210975Phase 3Suspended
- Sponsor
- Xinjiang Huakang Pharmaceutical
- Start
- May 2021
- Countries
- 1
01
Overview
A Phase 3 trial of suziafu tablets in Vitiligo, sponsored by Xinjiang Huakang Pharmaceutical. Started May 2021; status: suspended.
02
Drugs
suziafu tablets
03
Conditions
Vitiligo
Beyond the preview
Go deeper on CTR20210975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210975.